×

Before you go!

Sign up for the FREE weekly email newsletter from the publishers of American Nurse Today. You’ll get breaking news features, exclusive investigative stories, and more — delivered to your inbox.

Sign up today!

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Women's Health

September 2013 Vol. 8 No. 9

Author: Amanda Nenaber, MS, RN,

The Center for Devices and Radiological Health, part of the U.S. Food and Drug Administration (FDA), has launched a new program designed to look more closely at medical device use and the health of women (HoW). Goals of HoW include improving the consistent, and communication of information to patients . . .

September 2013 Vol. 8 No. 9

Author: Amanda Nenaber, MS, RN,

A study in Clinical Nursing Research reports that a 30-minute “therapeutic shower” taken when a woman is in active labor, can significantly reduce tension and anxiety and increase relaxation and coping.
Read more . . .

July 2013 Vol. 8 No. 7

Author: Rose O. Sherman, EdD, RN, NEA-BC, FAAN

Poor sleep quality and quantity during pregnancy can disrupt normal immune processes and may lead to lower birth weights and other complications, according to a study in Psychosomatic Medicine. The results of “Disturbed Sleep and Inflammatory Cytokines in Depressed and Nondepressed Pregnant Women: An Exploratory Analysis of Pregnancy Outcomes” indicate . . .

July 2013 Vol. 8 No. 7

Author: Rose O. Sherman, EdD, RN, NEA-BC, FAAN

A meta-analysis published by PLOSOne found that human papillomavirus (HPV) triples the risk for esophageal squamous cell carcinoma. Read more . . .

July 2013 Vol. 8 No. 7

Author: Rose O. Sherman, EdD, RN, NEA-BC, FAAN

On June 28, the U.S. Food and Drug Administration (FDA) approved Brisdelle (paroxetine) to treat moderate to severe hot flashes associated with menopause. Brisdelle, which contains the selective serotonin reuptake inhibitor paroxetine mesylate, is currently the only nonhormonal treatment for hot flashes approved by the FDA. Read more . . .

July 2013 Vol. 8 No. 7

Author: Rose O. Sherman, EdD, RN, NEA-BC, FAAN

The study “Smoking Cessation, Weight Change and Coronary Heart Disease Among Postmenopausal Women With and Without Diabetes,” published the Journal of the American Medical Association, found that postmenopausal women who quit smoking reduced their risk of heart disease, regardless of whether they had diabetes. Read more . . .

May 2013 Vol. 8 No. 5

Author: Leah Curtin, RN, ScD(h), FAAN

The quantum patient is an indivisible human being whose health
problems might not be healed through traditional specialization.

April 2013 Vol. 8 No. 4

Author: Sheyla Desir MSN, RN, CMSRN; Roseanne Fairchild PhD, RN, CNE, NE-BC

On April 8, the U.S. Food and Drug Administration (FDA) approved Diclegis (doxylamine succinate and pyridoxine hydrochloride) to treat pregnant women experiencing nausea and vomiting. Diclegis is a delayed-release tablet intended for women who have not adequately responded to conservative management of nausea and vomiting during pregnancy, such . . .

April 2013 Vol. 8 No. 4

Author: Cherrilyn F. Richmond, MS, FNP/WHNP-BC

Although painful and disruptive, interstitial cystitis often can be managed with drugs, bladder instillation and other procedures, and dietary changes. Most patients also need psychosocial support or professional counseling to deal with related stress, anxiety, depression, and frustration.

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing